A recent study demonstrated that tauopathy differs in hippocampal subregions (i.e., CA1, DG, CA3), indicating that ibrutinib might differentially regulate tau phosphorylation at Ser202/Thr205 in brain region‐specific manner in PS19 mice (Boluda et al., 2015). The gene discussed is MAPT; the disease is tauopathy.